Recruiting Now in Palo Alto Ca

New Migraine Clinical Trials in Palo Alto Ca

Medically Reviewed By
Dr. Sarah Jensen, MD, Board-Certified Rheumatologist

Residents of Palo Alto Ca, CA struggling with Migraine may qualify for a new investigational treatment study being conducted by leading Palo Alto Ca facilities.

No Insurance Needed
Identify New Options

Am I Eligible?

Check if you qualify for the Up to $1,200 compensation.

Diagnosed with Migraine?
Aged 18-65?
Live near Palo Alto Ca?

100% Free • No Insurance Required

FDA Guidelines Monitored
HIPAA Compliant Data
256-bit SSL Enrollment

Local Medical Insight

Clinical research for Migraine in Palo Alto Ca is supported by major CA medical networks and research universities, ensuring state-of-the-art care and oversight for all participants in Palo Alto Ca.

Location

The research center is conveniently located in Palo Alto Ca. Validation parking is provided for all visits. (Specific address revealed upon qualification).

Qualification

  • Age 18 - 65
  • Diagnosed with Migraine
  • Trying to find better management options

Available Trials in Palo Alto Ca

Observational Study to Assess Adverse Events When Adult Female Participants Are Treated With Ubrelvy (Ubrogepant) or Qulipta (Atogepant) During Pregnancy

RECRUITINGMigraine

Observational Study to Assess Maternal, Fetal and Infant Outcomes Following Exposure to Rimegepant

RECRUITINGMigraine

Clinical Trial of Endoscopically Guided Injection of Exparel (Bupivacaine) for the Treatment of Craniofacial Pain

RECRUITINGMigraine

Environmental Factors in Palo Alto Ca

Living in Palo Alto Ca presents unique lifestyle factors that can influence the management of Migraine. Local weather patterns and urban stressors are important considerations for ongoing clinical research.

Patient FAQ: Palo Alto Ca

Is travel compensation available?
Yes, many trials in the area provide stipends for travel expenses.
Do I need insurance?
No, all study-related care and medication are provided at no cost.
Can I keep my current doctor?
Absolutely. Study participation is a supplemental care option.